Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 23.45
-0.35 (-1.47%)
Jul 30, 2026, 12:40 PM CST
Allied Biotech Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 880.06 | 849.51 | 806.92 | 720.43 | 716.75 | 676.76 |
Revenue Growth | 12.44% | 5.28% | 12.01% | 0.51% | 5.91% | 9.50% |
Gross Profit Gross Profit Growth | 317.17 | 308.61 | 258.38 | 246.44 | 271.05 | 258.05 |
Operating Income Operating Income Growth | 130.82 | 120.34 | 88.12 | 88.71 | 99.78 | 111.67 |
Net Income Net Income Growth | 107.16 | 129.46 | 100.94 | 97.41 | 146.74 | 13.04 |
Earnings Per Share EPS Growth | 1.11 | 1.34 | 1.05 | 1.01 | 1.53 | 0.14 |
EPS Growth | -21.23% | 27.62% | 3.96% | -33.99% | 1018.40% | -83.52% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Manufacture and Sale of Carotenoids in Taiwan Manufacture and Sale of Carotenoids in Taiwan Growth | 802.92 | 778.61 | 738.52 | 594.09 | 669.23 | 641.69 |
Sale of Carotenoids in Europe Sale of Carotenoids in Europe Growth | 498.77 | 478.19 | 439.06 | 371.64 | 389.02 | 323.69 |
Sale of Carotenoids in China Sale of Carotenoids in China Growth | 54.62 | 57.16 | 67.28 | 69.45 | 68.69 | 70.28 |
Adjustments and Write-Off Adjustments and Write-Off Growth | -476.25 | -464.46 | -437.94 | -314.76 | -410.2 | -358.89 |
Total Total Growth | 880.06 | 849.51 | 806.92 | 720.43 | 716.75 | 676.76 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 852.38 | 853.91 | 987.24 | 724.77 | 793 | 1,144 |
Total Debt Total Debt Growth | 725.99 | 731.91 | 954.17 | 795.43 | 837.07 | 1,243 |
Net Cash (Debt) Net Cash Growth | 126.4 | 122 | 33.07 | -70.66 | -44.06 | -98.6 |
Net Cash Growth | -1.37% | 268.93% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.31 | 1.27 | 0.34 | -0.74 | -0.46 | -1.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 184.15 | 217.13 | 223.79 | 137.62 | 164.27 | 72.43 |
Capital Expenditures CapEx Growth | -40.02 | -33.58 | -26.81 | -47.91 | -54.66 | -49.99 |
Free Cash Flow Free Cash Flow Growth | 144.13 | 183.55 | 196.98 | 89.71 | 109.62 | 22.44 |
Free Cash Flow Growth | -23.56% | -6.82% | 119.58% | -18.16% | 388.49% | 744.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.04% | 36.33% | 32.02% | 34.21% | 37.82% | 38.13% |
Operating Margin | 14.87% | 14.16% | 10.92% | 12.31% | 13.92% | 16.50% |
Pretax Margin | 15.55% | 19.32% | 16.12% | 16.99% | 25.82% | 2.60% |
Profit Margin | 12.18% | 15.24% | 12.51% | 13.52% | 20.47% | 1.93% |
FCF Margin | 16.38% | 21.61% | 24.41% | 12.45% | 15.29% | 3.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.250 | 1.250 | 1.000 | 0.850 | 1.200 | 0.500 |
Dividend Per Share Growth | 25.00% | 25.00% | 17.65% | -29.17% | 140.00% | -37.50% |
Dividend Yield | 5.18% | 5.63% | 6.32% | 5.93% | 10.52% | 4.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.84 | 17.17 | 16.51 | 16.22 | 9.13 | 111.49 |
P/FCF Ratio | 10.25 | 12.11 | 8.46 | 17.62 | 12.23 | 64.80 |
PS Ratio | 2.48 | 2.62 | 2.07 | 2.19 | 1.87 | 2.15 |